… to the disease signature. Our work defines a robust genetic signature for IPF providing a …
as enables the identification of preclinical models that most closely resemble human IPF. …

… Volcano plots depicting features that are statistically significant in idiopathic pulmonary
fibrosis (IPF) lung tissue compared with control lung tissue at a false discovery rate <0.05 (blue …

… Therefore, we constructed a molecular genomic signature to predict the prognosis of IPF …
the performance of the genomic signature in the validation cohort. The signature showed an …

… (miRNA) gene signatures as biomarkers in patients with Idiopathic pulmonary fibrosis (IPF), …
identify potential miRNA or gene signatures to serve as novel biomarkers for survival in IPF …

… Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing IIP that has no effective therapy with
a mortality rate higher than many cancers; median survival from the time of diagnosis being …

… Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal … Thus, in this paper we apply
a novel large scale high … to identify a unique IPF proteome signature and give insight into …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We
previously published a genome-… size estimates, we performed a genome-wide meta-analysis …

… nintedanib, for treatment of patients with idiopathic pulmonary fibrosis (IPF). However, neither
… minimal effect on IPF-specific gene signature or alter translational modifications involved in …

… Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease characterized by epithelial
injury and chronic activation of invasive fibroblasts that deposit and remodel the extracellular …

… translational biomarker studies. Transcriptomic and proteomic disease signatures generated
from clinically relevant human … ” modeling can enable translational disease understanding, …